| P50 | author | Timothy Synold | Q78536675 |
| P2093 | author name string | S J Forman | |
| | V A Pullarkat | |
| | M R O'Donnell | |
| | S H Thomas | |
| | A P Nademanee | |
| | A S Stein | |
| | D S Snyder | |
| | P M Parker | |
| | R T Spielberger | |
| | A C Dagis | |
| | A Tsirunyan | |
| | J C Alvarnas | |
| | J Y C Wong | |
| P2860 | cites work | The World Health Organization (WHO) classification of the myeloid neoplasms | Q28202501 |
| | Palifermin for oral mucositis after intensive therapy for hematologic cancers | Q28298574 |
| | Statistical methods in cancer research. Volume II--The design and analysis of cohort studies | Q29615413 |
| | Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis | Q33643387 |
| | Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation | Q35750957 |
| | Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study | Q36478476 |
| | Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation | Q37496060 |
| | The Analysis of Failure Times in the Presence of Competing Risks | Q41031423 |
| | Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation | Q43733284 |
| | Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. | Q43860572 |
| | Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies | Q44246178 |
| | Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study | Q46679444 |
| | Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen. | Q46857947 |
| | Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies. | Q49305416 |
| | Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis. | Q52430685 |
| | Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Q54684597 |
| | A Proportional Hazards Model for the Subdistribution of a Competing Risk | Q56885139 |
| | Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression | Q67254005 |
| | Determination of busulfan in human plasma by gas chromatography with electron-capture detection | Q68369505 |
| | Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 |
| | Regimen-related toxicity in patients undergoing bone marrow transplantation | Q70215525 |
| | A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group st | Q70656728 |
| | Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia | Q73104276 |
| | Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study | Q73292530 |
| | Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia | Q74724465 |
| | A risk score for mortality after allogeneic hematopoietic cell transplantation | Q82892217 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phase II clinical trial | Q42824440 |
| P304 | page(s) | 1256-1262 | |
| P577 | publication date | 2010-12-13 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia | |
| P478 | volume | 46 | |